Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.45 CAD | -0.85% | -4.83% | -5.86% |
Sales 2024 * | 15.95M 11.6M | Sales 2025 * | 43.69M 31.76M | Capitalization | 257M 187M |
---|---|---|---|---|---|
Net income 2024 * | -38M -27.62M | Net income 2025 * | -30M -21.81M | EV / Sales 2024 * | 15.3 x |
Net cash position 2024 * | 13.74M 9.98M | Net Debt 2025 * | 41.34M 30.05M | EV / Sales 2025 * | 6.84 x |
P/E ratio 2024 * |
-6.76
x | P/E ratio 2025 * |
-7.5
x | Employees | 131 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.29% |
Latest transcript on Profound Medical Corp.
1 day | -1.40% | ||
1 week | -5.39% | ||
Current month | -7.71% | ||
1 month | -3.21% | ||
3 months | -3.74% | ||
6 months | -17.53% | ||
Current year | -5.05% |
Managers | Title | Age | Since |
---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 69 | 15-06-03 |
Rashed Dewan
DFI | Director of Finance/CFO | 56 | 15-06-30 |
Mathieu Burtnyk
COO | Chief Operating Officer | 42 | 11-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Rosenthal
BRD | Director/Board Member | 77 | 18-06-13 |
Director/Board Member | 67 | 18-06-13 | |
Cynthia Lavoie
BRD | Director/Board Member | - | 21-03-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 10.45 | -0.85% | 6 204 |
24-04-18 | 10.54 | -1.40% | 4,200 |
24-04-17 | 10.69 | -0.74% | 1,900 |
24-04-16 | 10.77 | -0.65% | 1,025 |
24-04-15 | 10.84 | -1.28% | 791 |
Delayed Quote Toronto S.E., April 18, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.05% | 187M | |
+2.02% | 207B | |
+2.17% | 175B | |
+10.45% | 132B | |
+16.62% | 99.1B | |
-4.41% | 60.89B | |
+13.38% | 52.04B | |
-6.33% | 45.48B | |
-4.74% | 38.81B | |
+9.89% | 38.77B |
- Stock Market
- Equities
- PRN Stock